Back to Agenda
LS31: New System of Clinical Notification for Complexed Clinical Trials
Session Chair(s)
Toshinori Higashi, PHD
Vice President, Regulatory Science, KAKEN PHARMACEUTICAL CO.,LTD., Japan
Speaker(s)
Daisuke Sato
Coordinator, Office of Review Management, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Noriko Morikubo
Regulatory Strategy Group2, Japan Regulatory Portfolio Lead, Pfizer R&D Japan G.K., Japan
Hitomi Okuma, MD, PHD
Head, International Research and Development Section, National Cancer Center Hospital, Japan
Have an account?